LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Clinical trials for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new LUNG NON-SMALL CELL SQUAMOUS CARCINOMA trials appear
Sign up with your email to follow new studies for LUNG NON-SMALL CELL SQUAMOUS CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Tough-to-Treat lung cancer: Four-Drug combo enters trial
Disease control OngoingThis study is testing whether adding a new drug called berzosertib to a standard three-drug treatment works better for people with advanced squamous cell lung cancer. It aims to control the cancer's growth and extend the time patients live without their disease getting worse. The…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Can a One-Two punch of radiation and immune therapy better fight lung cancer?
Disease control OngoingThis study is testing if combining a targeted, high-dose radiation treatment with an immunotherapy drug works better than radiation alone for certain early-stage or recurrent non-small cell lung cancers. About 140 participants will be randomly assigned to receive either the radia…
Matched conditions: LUNG NON-SMALL CELL SQUAMOUS CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 24, 2026 12:01 UTC